FIRST AIRED: June 3, 2018

Nice work! Enjoy the show!


You’re busy. We get it.

Stay on top of the news with our Editor’s Picks newsletter.

US Edition
Intl. Edition
Unsubscribe at any time. One click, it’s gone.

Thanks for signing up!



>> American medical researchers on Sunday, announced groundbreaking findings in treating a form of breast cancer. A new study shows some 70% of women with early stage breast cancer, with a low risk of recurrence. Can safely skip chemotherapy after their tumors are removed. The study, published in the New England Journal of Medicine, examined how to treat women with early stage breast cancer, that responds to hormone therapy.
It found that women over 50 with this type of cancer, and younger women with a low genetic likelihood of cancer recurrence. Could forego chemotherapy and be treated with hormone therapy. Chemotherapy is a category of drugs that target cancer cells, by preventing them from spreading. Adverse effects from chemotherapy can be severe, including nausea, hair loss, anemia, and weakened immune systems.
The American Society of Clinical Oncology, presented the findings of the study at a meeting in Chicago. It involved more than 10,000 women with breast cancer that had not yet spread to nearby lymph nodes, and who tested negative for a specific gene.